3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Carcinoma, Non-Small-Cell Lung
23
Melanoma
21
Carcinoma, Renal Cell
21
Neoplasms
8
Lung Neoplasms
8
Colorectal Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
7
Prostatic Neoplasms
7
Neoplasm Metastasis
6
Carcinoma, Transitional Cell
6
Carcinoma, Hepatocellular
6
Stomach Neoplasms
5
Rectal Neoplasms
5
Hodgkin Disease
5
Adenocarcinoma Of Esophagus
5
Triple Negative Breast Neoplasms
4
Ovarian Neoplasms
4
Nasopharyngeal Carcinoma
4
Endometrial Neoplasms
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Thyroid Neoplasms
3
Pancreatic Neoplasms
3
Oropharyngeal Neoplasms
3
Multiple Myeloma
3
Leukemia, Myeloid, Acute
3
Esophageal Neoplasms
3
Colonic Neoplasms
3
Brain Neoplasms
3
Anus Neoplasms
3
Interventions
cabozantinib
4
Nivolumab
2
Ipilimumab
2
zimberelimab
1
temsirolimus
1
salicylhydroxamic acid
1
orellanine
1
atezolizumab
1
Surveys and Questionnaires
1
Ropivacaine
1
Pluvicto
1
Methods
1
Health Promotion
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Genetic Counseling
1
Erlotinib Hydrochloride
1
Educational Status
1
Early Intervention, Educational
1
Docetaxel
1
Dacarbazine
1
Counseling
1
Blood Component Removal
1
Axitinib
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Nivolumab
×
30 days
×
Clear all
NCT04322955
2026-06-05
Cyto-KIK
Columbia University
Phase 2
Active not recruiting
38 enrolled
NCT07028125
2026-06-05
CANIQOL
Centre Francois Baclesse
Phase 4
Recruiting
83 enrolled